Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 10, 2026
Why Is Lincoln Educational Services (LINC) Stock Down -21.54% Today?

Why Is Lincoln Educational Services (LINC) Stock Down -21.54% Today?

Key Takeaways

  • Lincoln Educational Services shares plunged 21.54% to approximately $32.16 in Monday's session, erasing months of gains despite the company reporting better-than-expected Q2 earnings.
  • Student starts grew only 1% year-over-year, a dramatic deceleration from the 19.5% growth recorded in Q1 and the most significant factor rattling investor confidence.
  • Full-year guidance was merely reiterated, not raised, disappointing a market that had priced in continued upward revisions following the company's earlier 2026 guidance boost.
  • A steep sequential earnings decline — EPS fell from $0.14 in Q1 to $0.06 in Q2 — underscored the seasonal volatility in Lincoln's business model and raised margin sustainability questions.
  • Elevated valuation left no margin for error, with shares trading above 55 times trailing earnings before today's sell-off, amplifying the downside reaction to mixed results.
  • Traders are now watching whether August student enrollment data and management's third-quarter commentary can restore confidence in the growth narrative.

Opening Summary

Shares of LINC, Lincoln Educational Services Corporation — a leading provider of career-oriented post-secondary technical training in the United States — cratered 21.54% on Monday, tumbling from Friday's closing price of $40.99 to roughly $32.16 in morning trading. The sell-off came despite the company posting second-quarter results that exceeded Wall Street's revenue and earnings expectations. Headline numbers showed revenue of $142.6 million, up 22.4% year-over-year and ahead of the $138.9 million consensus, while GAAP earnings per share of $0.06 handily beat analyst forecasts for a loss of $0.01 per share. Yet the market focused on troubling details beneath the surface, triggering one of the stock's steepest single-day declines on record.

Student Starts Slowdown Sparks Growth Concerns

The most alarming revelation in Lincoln's Q2 report was the near-flat growth in student starts. After posting a blistering 19.5% year-over-year increase in student starts during the first quarter, the company disclosed that Q2 starts rose by only 1%. Management attributed the weakness to shifts in student decision-making patterns, noting that fewer enrolled students attended their first day of class during the quarter. For a company whose investment thesis rests squarely on expanding enrollment to meet America's skilled-trades labor shortage, a sudden halt in start growth represents a serious warning sign. Although CEO Scott Shaw expressed confidence that August starts would rank among the largest in company history, investors were unwilling to extend the benefit of the doubt.

Guidance Reiteration Disappoints a Rally-Priced Stock

Lincoln Educational entered the earnings report having already raised its full-year 2026 guidance earlier in the year to a range of $590 million to $600 million in revenue and adjusted EBITDA of $76 million to $80 million. With the company exceeding Q2 estimates, many investors had positioned for another upward revision. Instead, management simply reconfirmed the existing outlook. For a stock that had more than doubled over the preceding twelve months and carried a forward price-to-earnings ratio north of 55, the absence of a guidance raise was treated as a de facto disappointment. The market's reaction underscores how thoroughly bullish expectations had become embedded in LINC's valuation heading into the print.

Sequential Earnings Compression Highlights Seasonal Risks

While the $0.06 per-share profit beat the consensus estimate of a $0.01 loss, it represented a sharp sequential decline from the $0.14 earned in Q1 2026. That quarter-to-quarter drop of roughly 57% renewed scrutiny on Lincoln's seasonal earnings pattern and the margin pressures tied to its campus expansion strategy. Operating margin in Q2 came in at 2.3%, flat year-over-year, as selling, general, and administrative expenses rose 18.8% to $79.7 million — driven in part by costs associated with new campuses in Houston, Hicksville, and Rowlett. The company also raised its capital expenditure guidance by approximately $25 million to reflect a property acquisition in Melrose Park, Illinois, and a new campus in Suitland, Maryland. While these investments support long-term growth, they are compressing near-term profitability at a moment when the market is demanding operating leverage.

Market Context and Trading Activity

Monday's collapse did not occur in a vacuum. LINC had already been under significant selling pressure in recent sessions. On August 6, the stock tumbled 8.6% on volume of 1.25 million shares — more than double the 65-day average of approximately 573,000. That move came amid disclosures that institutional investors including Dimensional Fund Advisors (down 11.7%) and Arrowstreet Capital (down 58.1%) had reduced their positions, while company insiders had sold roughly $95,000 shares worth approximately $4.62 million over the prior three months. The stock had already fallen below both its 50-day simple moving average of $47.27 and was testing its 200-day moving average of roughly $40.85 before today's plunge decisively sliced through that floor as well. The broader education and consumer discretionary sectors have shown mixed performance, but LINC's decline was overwhelmingly company-specific, driven by the earnings release.

What Comes Next for LINC

The immediate focus for LINC shareholders shifts to the critical August enrollment period. Management's assertion that the upcoming class could be among the largest in company history will be tested against actual start data in the weeks ahead. The company's investment in a revamped high school recruiting platform is designed to reaccelerate student acquisition, but execution risks remain elevated following the Q2 disappointment. Analyst sentiment, which prior to earnings skewed decidedly bullish with four Buy ratings and a consensus price target above $54, may face downward revisions as the market digests the enrollment deceleration. With full-year EPS guidance of $0.74 to $0.83 implying a still-demanding valuation even after today's rout, any further evidence of slowing student momentum would compound the pressure. Conversely, a strong August cohort could rapidly restore confidence in the growth narrative and validate the sell-off as an overreaction.

Trending AI Robots

For traders seeking to navigate volatile markets with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to identify opportunities across thousands of tickers. Tickeron maintains hundreds of AI trading bots, each employing distinct strategies, timeframes, and performance metrics tailored to evolving market conditions. Only the strongest performers under current market dynamics are featured in this curated section, providing traders with a continuously updated window into which algorithmic approaches are generating the most consistent results. Explore the Trending AI Robots to discover which strategies are leading the pack.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LINC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


LINC sees MACD Histogram crosses below signal line

LINC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 06, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where LINC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

LINC moved below its 50-day moving average on July 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LINC crossed bearishly below the 50-day moving average on July 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LINC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LINC's RSI Indicator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on LINC as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LINC advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

LINC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 260 cases where LINC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LINC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LINC's P/B Ratio (6.540) is slightly higher than the industry average of (2.419). P/E Ratio (56.931) is within average values for comparable stocks, (30.474). LINC's Projected Growth (PEG Ratio) (3.459) is very high in comparison to the industry average of (1.291). Dividend Yield (0.000) settles around the average of (0.052) among similar stocks. P/S Ratio (2.357) is also within normal values, averaging (1.636).

Notable companies

The most notable companies in this group are TAL Education Group (NYSE:TAL).

Industry description

‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.

Market Cap

The average market capitalization across the Other Consumer Specialties Industry is 1.23B. The market cap for tickers in the group ranges from 90 to 8.91B. EDU holds the highest valuation in this group at 8.91B. The lowest valued company is BSEFY at 90.

High and low price notable news

The average weekly price growth across all stocks in the Other Consumer Specialties Industry was 2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -12%. VSA experienced the highest price growth at 29%, while JDZG experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Other Consumer Specialties Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was 0%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 67
Price Growth Rating: 62
SMR Rating: 78
Profit Risk Rating: 86
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
LINC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of higher education degrees, job training and vocational study programs

Industry OtherConsumerSpecialties

Profile
Details
Industry
Miscellaneous Commercial Services
Address
14 Sylvan Way
Phone
+1 973 736-9340
Employees
2640
Web
https://www.lincolntech.edu
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.